Resources

Type of publications
Regions
Diseases

5255 results found

2022 ∙ Baier, E. Olgemöller, U. Biggemann, L. Buck, C. Tampe, B.

Dual-Positive MPO-and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Feikin, Daniel R. Higdon, Melissa M. Abu-Raddad, Laith J. Andrews, Nick Araos, Rafael Goldberg, Yair Groome, Michelle J. Huppert, Amit O'Brien, Katherine L. Smith, Peter G. Wilder-Smith, Annelies Zeger, Scott Deloria Knoll, Maria Patel, Minal K.

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Addo, I. Y. Dadzie, F. A. Okeke, S. R. Boadi, C. Boadu, E. F.

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Buonsenso, D. Cusenza, F. Passadore, L. Bonanno, F. De Guido, C. Esposito, S.

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies

  • Newborn
  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kling, K. Domingo, C. Bogdan, C. Duffy, S. Harder, T. Howick, J. Kleijnen, J. McDermott, K. Wichmann, O. Wilder-Smith, A. Wolff, R.

Duration of protection after vaccination against yellow fever - systematic review and meta-analysis

  • All age groups
  • Travellers
  • Yellow fever
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ribeiro, T. B. Roque, F. Ida, F. Plácido, A. I. Vu, M. Hernández-Muñoz, J. J. Herdeiro, M. T.

Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods

  • All age groups
  • Healthcare workers
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Gurav, Yogesh Kirshnarao Bagepally, Bhavani Shankara Thakkinstian, Ammarin Chaikledkaew, Usa Thavorncharoensap, Montarat

Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review

  • All age groups
  • Low and Middle Income Countries
  • Hepatitis A
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Dilokthornsakul, P. Lan, L. M. Thakkinstian, A. Hutubessy, R. Lambach, P. Chaiyakunapruk, N.

Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis

  • Older adults
  • Healthcare workers
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Frianto, D. Setiawan, D. Diantini, A. Suwantika, A. A.

Economic Evaluations of HPV Vaccination in Targeted Regions of Low-and Middle-Income Countries: A Systematic Review of Modelling Studies

  • Adolescents
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Kong, G. Lim, N. A. Chin, Y. H. Ng, Y. P. M. Amin, Z.

Effect of COVID-19 Pandemic on Influenza Vaccination Intention: A Meta-Analysis and Systematic Review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...